Even as Indian equities tripled investor wealth post-pandemic, several marquee stocks—from paints to pharma and banks—are still languishing at pandemic-lows. Here’s why, and what it means for investors.
Even as Indian equities tripled investor wealth post-pandemic, several marquee stocks—from paints to pharma and banks—are still languishing at pandemic-lows. Here’s why, and what it means for investors.